万泰生物(603392.SH)已成功研制并推出“寨卡病毒、登革病毒、基孔肯雅病毒核酸检测试剂盒（PCR-荧光探针法）”

Core Viewpoint - Wanta Bio (603392.SH) has developed vaccine technology and successfully launched PCR-fluorescent probe test kits for Zika virus, dengue virus, and chikungunya virus, enabling precise identification of chikungunya virus infections in blood samples [1] Group 1 - The company possesses relevant vaccine development technology reserves [1] - The company has successfully developed and launched nucleic acid test kits for Zika virus, dengue virus, and chikungunya virus [1] - The test kits can accurately identify whether blood samples are infected with chikungunya virus [1]